Aim Biliary atresia (BA) is a neonatal liver disease defined as chronic progressive fibrotic
obliteration of extrahepatic bile ducts. The objective of this study was to determine the …

Biliary atresia (BA) is a challenging liver disease in infancy. Early diagnosis of BA is
important for timely hepatoportoenterostomy. We evaluated the age‐specific diagnostic …

Objective Liver transient elastography (TE) using FibroScan® has gained popularity as a
non-invasive technique to assess hepatic fibrosis by measuring liver stiffness. This study …

We investigated the utility of transient elastography (TE) for diagnosing biliary atresia (BA) in
cholestatic infants and predicting the outcome of BA. Forty‐eight cholestatic infants (9‐87 …

AIM: To analyze plasma osteopontin levels and liver stiffness using transient elastography in
postoperative biliary atresia (BA) children compared with healthy controls. METHODS: Thirty …

Background and aim: Biliary atresia (BA) is an intractable neonatal liver disease
characterized by progressive fibrosclerotic obliteration of the extrahepatic biliary tree. The …

Background The progression of hepatic fibrosis may result in decompensated hepatic failure
with cirrhosis, liver related events (LRE) such as ascites, variceal bleeding, and death after …

Background Biliary atresia (BA) is a neonatal liver disorder characterized by chronic
inflammation and obliteration of extrahepatic bile ducts. The purpose of the study was to …

AIM To investigate serum urokinase-type plasminogen activator receptor (uPAR) and liver
stiffness in biliary atresia (BA) and examine the correlation of circulating uPAR, liver …

Background Validated non-invasive examinations are necessary to monitor liver fibrosis in
children with biliary atresia (BA) after the Kasai procedure. Purpose To evaluate the …